The incidence of recurrent DVT is higher among patients less than 65 years of age and patients with idiopathic DVT, irreversible thrombotic risk, primary hypercoagulopathy essentially factor V R 506 Q-Leiden (FVL) mutation, and hyperhomocysteinemia [20]. Here, F5 is linked to hyperhomocysteinemia.